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BACKGROUND:  One of the features associated with pre-eclampsia is elevated liver transaminases. The 
reason this happens has not been fully described. However, the hepatocytes are not known to be spared 
by free radical injury. This study was conducted to examine the relationship between product of free 
radical injury (malondialdehyde) and transaminases in pre-eclamptic women. 
PATIENTS AND METHODS: A total of 98 and 115 pre-eclamptic and apparently normal pregnant 
women were selected from the booking clinic of Ladoke Akintola University of Technology Teaching 
Hospital, Osogbo. Non-pregnant women were selected from volunteered members of staff. 
Malondialdehyde (MDA), aspartate transaminase (AST) and alanine transaminase (ALT) analyses were 
determined on collected venous blood sample. Statistical analyses of variables were done using SPSS 17 
taking level of significance to be p<0.05. 
RESULTS: Subjects with plasma AST between 10 and 20U/L had mean plasma MDA of 0.92µmol/l 
whereas those with plasma levels greater than 41U/L had mean plasma MDA of 4.72µmol/l. Similarly, 
Subjects with plasma ALT between 10 and 20U/L had mean plasma MDA of 0.86µmol/l, and subjects 
with plasma ALT greater than 51 U/L had mean plasma MDA of 4.71µmol/l. Positive correlation was 
observed between AST and ALT(r=0.79;p=0.047), between AST and MDA(r=0.690; p=0.061) as well as 
between ALT and MDA(r=0.571;p=0.049). 
CONCLUSION: The elevated liver enzymes seen in women with pre-eclampsia may be due to free 
radical injury to the liver. Pre-eclamptic women without free radical injury did not have elevated 
transaminases  
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Pregnancy may be complicated with pre-
eclampsia (1,2). A study in Nigeria found a 
prevalence of 6.5%
2
. The underlying pathogenesis 




injury has been linked with pre-eclampsia (5,6). 
Despite the unknown pathogenesis, reduced blood 
flow to the placenta resulting in hypoperfusion 
and diffuse endothelia cell injury are considered as 
the central pathologic events (7). Adequate 
maternal-foetal exchange is a key requirement for 
a successful pregnancy (8).  Early in pregnancy, 
maternal blood flow is absent from the precursors 
of the intervillous space (IVS). Therefore, a 
capillary circulation or simple diffusion performs 
the exchange of oxygen, nutrients and waste 
products (8).  Around the 10
th
 week of gestation, 
oxygen tension rises as a result of maternal blood 
flow into IVS.  
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With this, there is generation of reactive oxygen 
spices, free radical (oxidant) (8)
 
which may lead to 
oxidative stress. Oxidative stress occurs when 
there is an imbalance in oxidant and antioxidant in 
excess of oxidant (9,10). Free radicals, because of 
their nature of attack on cellular organelles behave 
like oxidants. The attack of free radical on 
polyunsaturated membrane lipid gives 
hydroperoxide with subsequent production of 
malondialdehyde (MDA). This attack on 
membrane lipid is termed as lipid peroxidation, 
and malondiadehyde is now measured as the 
product of free radical injury on membrane lipid 
(11). The attack of free radical on polyunsaturated 
membrane lipid results in hydroperoxide with 
subsequent production of malondialdehyde 
(MDA).  
One of the features associated with pre-
eclampsia is elevated liver transaminases. Why 
this happenes has not been fully described (12,13). 
However, the hepatocytes are not known to be 
spared by free radical injury (14). This study, 
therefore, was designed to determine the 
association that may exist among plasma levels of 
aspartate amnino transaminase (AST), alanine 
amino transaminase (ALT) and malondialdehyde 
in women with preeclampsia.  
 
MATERIALS AND METHODS  
 
The study site was Ladoke Akintola University of 
Technology Teaching Hospital, Osogbo, Nigeria. 
This study was a cross sectional and prospective 
cohort type.There were 98 pre-eclamptic and 115 
apparently normal pregnant women recruited into 
the study. All subjects were in their second 
trimester. All selected subjects at first contact 
were all above 20 weeks of gestation. Ninety (90) 
age matching, apparently healthy non-pregnant 
women were also recruited from the volunteered 
members of staff as controls. Women previously 
known to be hypertensive and those with other 
complications of pregnancy such as gestational 
diabetes, multiple gestation, jaundice in pregnancy 
and cancer coexisting with pregnancy were 
excluded from the study. All recruited subjects 
were not on any medication other than routine 
self-prescribed haematinics. None of our pre-
eclamptic women was on antihypertensive as they 
were all recruited from the booking clinic.Ethical 
clearance for the study was obtained from the 
Ethical Committee of Ladoke Akintola University 
of Technology Teaching Hospital, Osogbo in 
accordance with Helsinki declaration. 
After taking an informed consent, about 10ml 
of venous blood was collected into lithium heparin 
containing specimen bottle. This was taken from 
antecubital fossa following aseptic procedure of 
venepuncture from each subject and control. Each 
batch of samples was centrifuged at 3000g for 5 
min. Carefully, plasma was separated into plain 
screw cap specimen bottles. The plasma samples 
were used for MDA, AST and ALT assay. 
Malondialdehyde (MDA) was estimated using 
method of Satoh et al (15) because it is a 
thiobarbituric acid reacting substance. After the 
initial precipitation by trichloroacetic acid (TCA), 
the reaction of MDA with thiobarbituric acid gives 
a red coloured complex that is read 
spectrophotometrically at 532nm.. Aspartate 
amino transaminase was measured using the 
method of Bergeyer
  
et al (16). This method was 
based on the principle that oxaloacetate is formed 
from the reaction of α- oxoglutamate and L-
aspartate reduces NADH
+ 
by the help of malate 
dehydrogenase. The reduced NADH
+
 is measured 
spectrophotometrically at 340nm. Alanine amino 
tranaminase was measured also 
spectrophometrically from reduced NADH
+
 
formed from the reaction of α- oxoglutarate and L-
alanine. This reaction is catalyzed by alanine 
amino transaminase (17).
 
Each of these 
biochemical parameters was run in a batch of 30 
samples.  The data were entered and analysed 
using Statistical Package for the Social Sciences 
(SPSS) version 17.0 setting level of significance at 




Table 1 shows the mean age distributions of the 
study groups. There was no statistically significant 
difference (P>0.05) in age of the study groups. 
There was no statistically significant difference 
(p>0.05) also in the mean values of body mass 
index within the groups. There was no statistically 
significant difference (p>0.05) in systolic blood 
pressure (SBP) (mmHg) among the study groups. 
Similar findings were observed in diastolic blood 
pressure (DBP) (mmHg). 
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Table 1: Comparison of Mean±SD of Clinical Variables/Parameters  
 
Variables  Comparison Mean ±SD p-Values 
Age  (year) NonP Vs NP 
NonP Vs PE 
NP Vs PE 
25.26±5.32 Vs 28.87±6.62 
25.26±5.32 Vs 28.87±4.33 






) NonP Vs NP 
NonP Vs PE 
NP Vs PE 
24.32±4.14 Vs 23.46±4.38 
24.32±4.14 Vs 24.60±3.50 




GA (week) NP Vs PE 24.28±5.81 Vs 24.03±1.73 >0.05 
SBP (mmHg) NonP Vs NP 
NonP Vs PE 
NP Vs PE 
121.60±12.20 Vs 117.83±13.03 
121.60±12.20 Vs 166.15±9.40 




DBP (mmHg) NonP Vs NP 
NonP Vs PE 
NP Vs PE 
69.30±8.07 Vs 70.87±9.65 
69.30±8.07 Vs 99.80±2.66 




NP-Normal pregnant women , PE- Pre-eclamptic women, NonP-Non pregnant women,    * Statistically significant (p<0.05) 
         
Table 2 shows comparison of mean of 
biochemical variables. Higher level, although not 
statistically significant (p>0.05) of AST(U/L), was 
observed in the normal pregnancy group compared 
with non-pregnant women. There was 
significantly higher value (p<0.03) of AST (U/L) 
in pre-eclamptic women compared with non- 
pregnant women. Also, significantly higher value 
(p<0.05) of AST was observed in pre-eclamptic 
group than in the normal pregnancy group. Similar 
findings were observed when ALT was compared 
among the study groups. Statistically significant 
higher level of plasma MDA (µmol/l) was 
observed in normal pregnancy group compared 
with non-pregnant group. In the same vein, 
significant (p<0.0001) higher plasma level of 
MDA (µmol/l) was observed in women with pre-
eclampsia (3.00±2.21) compared with non- 
pregnant women. Furthermore, plasma MDA 
(µmol/l) was found to be significantly higher 
(p<0.0001) in pre-eclamptic group than in the 
normal pregnancy group. 
Plasma AST and ALT in pre-eclamptic 
subjects were divided into different ranges with 
their corresponding mean MDA values (Table 3). 
There was corresponding increase in MDA with 
the increase in AST and ALT. 
 
Table 2: Comparison of Mean±SD of Biochemical Parameters. 
 
Variables  Comparison Mean ±SD p-Values 
    
AST (U/L) NonP Vs NP 
NonP Vs PE 
NP Vs PE 
12.32±6.45 Vs 19.15±8.69 
12.32±6.45 Vs 34.75±24.75 





ALT (U/L) NonP Vs NP 
NonP Vs PE 
NP Vs PE 
8.05±4.19 Vs 15.97±5.41 
8.05±4.19 Vs 37.51±23.89 





MDA(µmol/l) NonP Vs NP 
NonP Vs PE 
NP Vs PE 
0.96±0.68 Vs 1.65±0.62 
0.96±0.68 Vs 3.00±2.21 









NP-Normal pregnant women, PE- Pre-eclamptic women, NonP-Non pregnant women,  * statistically significant 
(p<0.05) 




 Range  Category  Mean MDA(µmol/l) 
    
AST (U/L) 10-44.75 10-20 0.92 
  21-30 1.89 
  31-40 3.61 
  >41 4.72 
ALT(U/L) 13.62-71.40 10-20 0.86 
  21-30 1.12 
  31-40 3.20 
  41-50 4.61 
  >51 4.71 
 
Table 4 shows correlation of biochemical 
parameters in pre-eclamptic subjects. There was a 
positive correlation between gestational age 
(GA/wk) and AST between GA and ALT and 
between GA and MDA. Positive correlation were 
observed also between AST and ALT between 
AST and MDA as well as between ALT and 
MDA. Correlations of MDA and AST as well as 
with ALT are represented also in Figures 1 and 2. 
 
Table 4: Correlation of Variables in Pre-Eclamptic Women. 
 
 
 Age  BMI GA AST ALT MDA 
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Figure 1: Correlation of Plasma MDA and ALT 
 
 












The age differences among our subjects and 
controls were not significant. This resulted in good 
unbiased comparison of our biochemical 
parameters because of the influence of advancing 
age on plasma MDA. Malondialdehyde has been 
observed to be increasing with age (18). Influence 
of body weight on MDA (19) was also eliminated 
since body mass indexes of our subjects and 
controls were similar. The addictive contributions 
of body weight on these selected parameters was 
eliminated. As pregnancy advances, there are 
many metabolic changes that accompany it, and 
these occur in both normal and complicated 
pregnancies. Gestational ages of recruited normal 
and pre-eclamptic women were similar. There was 
no statistically significant difference. This has also 
helped to eliminate the influence of pregnancy 
advancement on our analyzed biochemical 
parameters. Aspartate
16
, alanine transaminases 
(20) and malondialdehyde (21) have been found to 
increase as pregnancy advances. One of the 
criteria in diagnosing pre-eclampsia is elevated 
blood pressure (22). Our study found significantly 
higher values of systolic and diastolic blood 
pressure in pre-eclamptic group compared with 
normal pregnant group and non-pregnant controls. 
This has given us a fair basis for truly recruiting 
these subjects as clinical cases of pre-eclampsia.  
In our study, the observed increase in plasma 
malondialdehyde levels in pre-eclamptic women 
compared with normal pregnant and non-pregnant 
women is in agreement with a similar study which 
reported significantly elevated levels of 
malondialdehyde in both normal and pre-
eclamptic pregnant women (23). This may be due 
to overwhelming free radical injury or insufficient 
antioxidant status in this group of people. Free 
radical injury can affect many organs in the body 
irrespective of its origin. It can attack cellular 
membrane of organs with production of MDA as 
an intermediate product. This was measured based 
on an unstable nature of free radical itself in the 
body system (24). The damage to cellular 
membrane allows cell contents to be released in 
the blood, degree which depends on the severity of 
membrane damage. There is no study so far in the 
literature to show specificity of damage to a 
particular organ by free radical. Therefore, its 
effect on hepatocytes may be accessed through 
plasma liver enzymes (transaminases). The 
transaminases (AST, ALT) are markers of 
hepatocellular injury. It should be born in mind 
that aspartate amino transaminase is present in 
other tissues like cardiac muscle, skeletal muscle 
and red cells. Therefore, the study was also 
designed to measured Alanine amino 
transaminase, a cytosolic enzyme which is found 
in its highest concentrations in the liver and is 
more specific to the liver.  
This study observed a higher level of AST 
and ALT in pre-eclamptic women compared with 
normal pregnant and non-pregnant women. This is 
already an established fact; HELLP (haemolysis, 
elevated liver enzymes and low platelet) syndrome 
is a known feature of pre-eclampsia (11). 
However, its pathogenesis has not been fully 
explained (13). Yet, haemolysis may be 
responsible for the elevation of AST due to its 
presence in red blood cells. It can also be 
suggested that the effect of free radical injury on 
red blood cell membrane has led to haemolysis. 
Elevated AST may also be due to an insult from 
free radical injury to the hepatocytes. This is 
evidenced by the accompany elevation of ALT 
which has been said to be more liver-specific. This 
free radical injury in our study was evidenced by 
corresponding increase in plasma 
malondialdehyde, a product of free radical injury. 
Free radical injury to the liver has been established 
from the finding of a previous study (14). 
However, hepatic insult could occur without free 
radical injury. It should also be noted that this free 
radicals could also affect other tissues where these 
enzymes are also present (25). Nevertheless, this 
study was able to ascertain that the free radical 
injury could be initiated by pre-eclampsia. 
This study demonstrated that the higher the 
AST and ALT, the higher the plasma 
malondialdehyde. The severity of free radical 
injury could be measured by plasma MDA, and 
also the severity of hepatic involvement could be 
assessed by plasma AST and ALT. We observed 
that the higher the plasma MDA, the higher the 
plasma liver enzymes. One can deduce from the 
findings of this study that pregnant women with 
pre-eclampsia without free radical injury 
(oxidative stress) may not have elevated liver 
enzymes.   
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We therefore conclude that there was an increased 
production of MDA correlating with elevated liver 
enzymes. The elevated liver enzymes seen in 
women with pre-eclampsia may be due to free 
radical injury to the liver. Pre-eclamptic women 
without free radical injury did not have elevated 
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